Eliminate OASIS-C2 Risks (SN, OT, ST, PT - 1.5)

Content
1 module

Rating

Course Length
60 mins

Instructor
Aaron Timmer

Price
$20.00

Description

The OASIS-C2 brought significant changes that affect clinicians' assessment strategies and require renewed focus to ensure compliant application of guidance. This presentation will include the three new items and their importance in risk adjustment of one of the new IMPACT outcomes, subtle modification in five items to facilitate cross-setting standardization with other post-acute care settings, the importance of adhering to a uniform "look-back" time period, and significant guidance in manual changes - especially in pressure ulcers.

Objectives

Learners will gain knowledge in OASIS-C2 areas at risk for data inaccuracy due to:
1. Inadequate understanding of three new OASIS items and their importance as risk covariates for the IMPACT measure “Percent of Patients with Pressure Ulcers that are New or Worsened”
      a. (M1028) Active Diagnoses 
      b. (M1060) Height & Weight 
      c. (GG0170C)Mobility
2. Insufficient recognition of subtle modifications in five items for standardization with other post-acute data collection for two IMPACT measures as identified
      a. “Percent of Patients with Pressure Ulcers that are New or Worsened”
            i. (M1311) Current Number of Unhealed Pressure
Ulcers
            ii. (M1313) Worsening in Pressure Ulcer Status
      b. “Drug Regiment Review Conducted with Follow-up for Identified Issues”
            i. (M2001) Drug Regimen
Review
            ii. (M2003) Medication Follow-up
            iii. (M2005) Medication Intervention
3. Failure to adhere to a uniform “look back” period in five items collected at Transfer & Discharge
      a. (M1501) Symptoms in Heart Failure
Patients
      b. (M1511) Heart Failure Follow-upc. (M2016) Patient/Caregiver Drug Education Intervention
      d. (M2301) Emergent Care
      e. (M2401) Intervention Synopsis 
4. Significant guidance changes for pressure ulcer

Learners will know how to apply OASIS-C2 guidance to patient scenarios:
1. Brief case studies related to new items (M1028, M1060, & GG0170C)
2. Brief case study related to pressure ulcer worsening (SOC to Discharge)
3. Brief case study related to drug regimen review and follow-up (SOC to Discharge)
4. Question/Answer & Evaluation (10 min)

Certificate

By completing/passing this course, you will attain the certificate HCAF Course Certificate

Learning Credits

CE
1.5
1
HCAF: Eliminate OASIS-C2 Risks
{{ vm.helper.t('reports.module') }}
Currently no reviews submitted

Shopping Cart

Your cart is empty